Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

Objectives. To evaluate the efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) who are refractory to conventional immunosuppressive therapy. Methods. Eligible patients received rituximab at a dose of 1,000 mg at days 1, 15, 169, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mod Rheumatol
Autors principals: Tanaka, Yoshiya, Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Sumida, Takayuki, Mimori, Tsuneyo, Koike, Takao, Endo, Kazuhiro, Mashino, Naomi, Yamamoto, Kazuhiko
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732415/
https://ncbi.nlm.nih.gov/pubmed/26054418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14397595.2015.1060665
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars